| ISA | ALKYLATING-DRUG |
| ANCESTORS | ALKYLATING-DRUG ALL ANTINEOPLASTIC-AGENT DRUG MATERIAL OBJECT PHARMACEUTICAL-MATERIAL PHYSICAL-OBJECT THERAPEUTICAL-MATERIAL |
| L-asparaginase | definition: alkylating anticancer drug used in the treatment of acute lymphoblastic leukemia (ALL) and lymphoma. Possible side effects are swelling and burning of veins, nausea and vomiting, fever, abdominal pain, diabetes and chills. Intravenous and intramuscular administration. (en) number: mass part of speech: noun reliability code: 10 term type: main entry term context (x): i_laspar.txt origination date: 04/06/2002 |
| asparaginase | definition: see L-asparaginase (en) number: mass part of speech: noun reliability code: 10 term type: synonym |
| Elspar | definition: see L-asparaginase (en) number: mass part of speech: noun reliability code: 10 term type: synonym |
| L-asparaginasa | definition: fármaco alquilante antineoplásico, utilizado para el tratamiento de la leucemia aguda linfoblástica y linfoma. Los efectos secundarios más comunes son nauseas, vómitos, inflamación y quemazón venosa, malestar abdominal, diabetes y escalofríos. Administración intramuscular e intravenosa. (es) gender: feminine number: mass part of speech: noun reliability code: 10 term type: main entry term context (x): e_laspar.txt origination date: 04/06/2002 |